Health and Healthcare

AstraZeneca : AZN

All AstraZeneca Articles

218 Articles

Chris Lange | Feb 1, 2017 at 3:11 PM EST

Top 6 Earnings To Watch For On Thursday

Although this earnings season has been relatively positive, the Dow has stepped away from its 20,000 mark, and it seems…

Paul Ausick | Dec 7, 2016 at 4:04 PM EST

Hanesbrands, AstraZeneca Plop into Wednesday’s 52-Week Low Club

December 7, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in…

Paul Ausick | Dec 5, 2016 at 4:04 PM EST

FitBit, Teva Slide into Monday’s 52-Week Low Club

December 2, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in…

Paul Ausick | Nov 22, 2016 at 4:04 PM EST

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in…

Chris Lange | Nov 6, 2016 at 10:25 AM EST

Top 10 Earnings Coming This Week

24/7 Wall St. has put together a preview of Disney, Petrobras and some of the other major companies reporting their…

Trey Thoelcke | Oct 21, 2016 at 7:45 AM EDT

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even…

Lee Jackson | Oct 13, 2016 at 10:40 AM EDT

Top 5 Jefferies Big Pharma Stock Picks for Q4

A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good…

Jon C. Ogg | Sep 23, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and…

Lee Jackson | Sep 21, 2016 at 8:25 AM EDT

Top Jefferies Stock Picks to Buy Now Also Pay Good Dividends

One of the best things for investors to do is look for solid growth potential combined with fair valuations. Sprinkle…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Jon C. Ogg | Sep 12, 2016 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include Colgate-Palmolive, Gilead Sciences, Navistar, Occidental Petroleum, Pandora Media…

Chris Lange | Aug 29, 2016 at 12:50 PM EDT

Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research…

Jon C. Ogg | Aug 29, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square and T-Mobile.

Chris Lange | Aug 14, 2016 at 10:05 AM EDT

Top 6 Companies That Destroyed Shareholders Last Week

The broad markets are continuing to hit all-time highs as the market is shifting gears out of the earnings season.…

Jon C. Ogg | Aug 8, 2016 at 12:45 PM EDT

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise…

1 … 5 6 7 8 9 … 15

AstraZeneca : AZN

All AstraZeneca Articles

Top 6 Earnings To Watch For On Thursday

Hanesbrands, AstraZeneca Plop into Wednesday’s 52-Week Low Club

FitBit, Teva Slide into Monday’s 52-Week Low Club

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

Top 10 Earnings Coming This Week

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Top 5 Jefferies Big Pharma Stock Picks for Q4

Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More

Top Jefferies Stock Picks to Buy Now Also Pay Good Dividends

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More

Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More

Top 6 Companies That Destroyed Shareholders Last Week

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

AstraZeneca : AZN

All AstraZeneca Articles

Top 6 Earnings To Watch For On Thursday

Hanesbrands, AstraZeneca Plop into Wednesday’s 52-Week Low Club

FitBit, Teva Slide into Monday’s 52-Week Low Club

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

Top 10 Earnings Coming This Week

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Top 5 Jefferies Big Pharma Stock Picks for Q4

Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More

Top Jefferies Stock Picks to Buy Now Also Pay Good Dividends

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More

Why AstraZeneca Could Gain Another 15% Despite Market Headwinds

Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More

Top 6 Companies That Destroyed Shareholders Last Week

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan